logo

For the Inventor, By the Inventor

Or-Akiva, Israel

Dexcel Pharma Technologies Ltd.

USPTO Granted Patents = 20

% Expired Patents = 5.0



Trademarks = 10

Forward Citations = 231

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Adel Penhasi (7 out of 15 patents)

silverMedal Tomer Gold (4 out of 4 patents)

bronzeMedal Ron Schlinger (4 out of 11 patents)

4.  Avi Avramoff (4 out of 15 patents)

5.  Dan Oren (4 out of 4 patents)

6.  Sheera Moses-Heller (4 out of 4 patents)

7.  Michael Grishko (3 out of 3 patents)

8.  Tal Hagigit (3 out of 3 patents)

9.  Ezra Hanuka (3 out of 5 patents)

10.  Eyal Shoshani (3 out of 3 patents)

11.  Abraham Jacob Domb (3 out of 12 patents)

12.  Corinna Tissen (2 out of 2 patents)

13.  Caterina Kreyenborg (2 out of 2 patents)

14.  Elisabeth Meimberg (2 out of 2 patents)

15.  Karl-Heinz Bannefeld (2 out of 2 patents)


20 patents:

1. 12599565 - Stable benzimidazole formulation (2026-04-14),
2. 12454693 - Nucleic acids for inhibiting expression of transferrin receptor 2 (2025-10-28),
3. 11986554 - Orally disintegrating compositions (2024-05-21),
4. 11304961 - Compositions comprising dexamethasone (2022-04-19),
5. 11299583 - Alternating and semi-alternating poly(ester-anhydride) copolymers (2022-04-12),
6. 11141488 - Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic (2021-10-12),
7. 11096948 - Methods for treatinginfection (2021-08-24),
8. 11077055 - Orally disintegrating compositions (2021-08-03),
9. 10835488 - Stable orally disintegrating pharmaceutical compositions (2020-11-17),
10. 10774176 - Alternating and semi-alternating poly(ester-anhydride) copolymers (2020-09-15),
11. 10736855 - Compositions comprising proton pump inhibitors (2020-08-11),
12. 10537585 - Compositions comprising dexamethasone (2020-01-21),
13. 10172882 - Pharmaceutical compositions comprising ferric citrate and methods for the production thereof (2019-01-08),
14. 10076494 - Stable orally disintegrating pharmaceutical compositions (2018-09-18),
15. 9889090 - Method for treating a periodontal disease (2018-02-13),
Company Overview
Dexcel Pharma Technologies Ltd. is a pharmaceutical company based in Or-Akiva, Israel, specializing in the development and manufacturing of innovative drug delivery systems. The organization focuses on enhancing therapeutic efficacy through advanced formulations and technologies, catering to a diverse range of therapeutic areas. Dexcel is committed to research and development, leveraging its expertise to create solutions that improve patient outcomes and streamline the drug development process.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

20 Patents

#2 in Or-Akiva

#306 in Israel

#31,295 in the World

Or-Akiva, IL
Or-Akiva, Israel

Dexcel Pharma Technologies Ltd.

Forward Citations = 231

22 inventors:

goldMedal Adel Penhasi (7 out of 15 patents)

silverMedal Tomer Gold (4 out of 4 patents)

bronzeMedal Ron Schlinger (4 out of 11 patents)

4.  Avi Avramoff (4 out of 15 patents)

5.  Dan Oren (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dexcel Pharma Technologies Ltd.. Retrieved from https://idiyas.com/company/dexcel-pharma-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…